Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| KORU Medical Systems, Inc. | 221,592 | reported | 02 Jan 2026 | tx 32+225,727 |
| NASTECH PHARMACEUTICAL CO INC | 75,000 | reported | 02 Sept 2011 | tx 1+75,000 |
| CANCER GENETICS, INC | 23,895 | reported | 17 Jan 2023 | tx 12+155,597 |
| PANACOS PHARMACEUTICALS, INC. | 15,000 | reported | 19 Jun 2008 | tx 6+67,500−15,000 |
| ClearPoint Neuro, Inc. | 12,820 | reported | 21 May 2026 | tx 52+266,871−50,663 |
| AUTOIMMUNE INC | 6,500 | reported | 22 May 2009 | tx 16+84,500 |
| NMT MEDICAL INC | 6,000 | reported | 22 Jun 2004 | tx 1+6,000 |
| AXCELIS TECHNOLOGIES INC | 1,354 | reported | 17 Feb 2021 | tx 41+536,025−187,631 |
| OptiNose, Inc. | 0 | reported | 21 May 2025 | tx 6+202,500−13,498 |
| SPECTRANETICS CORP | 0 | reported | 09 Aug 2017 | tx 27+252,733−337,733 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | ClearPoint Neuro, Inc. | 12,820 | 0.00 USD | deriv |
| 19 May 2026 | EXERCISE | ClearPoint Neuro, Inc. | 12,417 | — | |
| 19 May 2026 | EXERCISE | ClearPoint Neuro, Inc. | 12,417 | — | deriv |
| 02 Jan 2026 | GRANT_AWARD | ClearPoint Neuro, Inc. | 422 | 13.68 USD | |
| 02 Jan 2026 | GRANT_AWARD | KORU Medical Systems, Inc. | 3,872 | 5.81 USD | |
| 02 Oct 2025 | GRANT_AWARD | KORU Medical Systems, Inc. | 5,874 | 3.83 USD | |
| 01 Oct 2025 | GRANT_AWARD | ClearPoint Neuro, Inc. | 265 | 21.79 USD | |
| 02 Jul 2025 | GRANT_AWARD | KORU Medical Systems, Inc. | 6,284 | 3.58 USD | |
| 01 Jul 2025 | GRANT_AWARD | ClearPoint Neuro, Inc. | 484 | 11.94 USD | |
| 22 May 2025 | GRANT_AWARD | ClearPoint Neuro, Inc. | 12,417 | 0.00 USD | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 3,566 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 4,266 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 5,666 | — | deriv |
| 16 May 2025 | EXERCISE | ClearPoint Neuro, Inc. | 21,093 | — | |
| 16 May 2025 | EXERCISE | ClearPoint Neuro, Inc. | 21,093 | — | deriv |
| 02 Apr 2025 | GRANT_AWARD | KORU Medical Systems, Inc. | 8,806 | 2.56 USD | |
| 01 Apr 2025 | GRANT_AWARD | ClearPoint Neuro, Inc. | 486 | 11.89 USD | |
| 03 Jan 2025 | GRANT_AWARD | KORU Medical Systems, Inc. | 5,905 | 3.81 USD | |
| 02 Jan 2025 | GRANT_AWARD | ClearPoint Neuro, Inc. | 375 | 15.38 USD | |
| 01 Oct 2024 | GRANT_AWARD | ClearPoint Neuro, Inc. | 515 | 11.21 USD | |
| 01 Oct 2024 | GRANT_AWARD | KORU Medical Systems, Inc. | 8,181 | 2.75 USD | |
| 11 Jul 2024 | GRANT_AWARD | KORU Medical Systems, Inc. | 8,371 | 2.71 USD | |
| 01 Jul 2024 | GRANT_AWARD | ClearPoint Neuro, Inc. | 1,072 | 5.39 USD | |
| 06 Jun 2024 | GRANT_AWARD | OptiNose, Inc. | 85,000 | 0.00 USD | deriv |
| 16 May 2024 | GRANT_AWARD | ClearPoint Neuro, Inc. | 21,093 | 0.00 USD | deriv |
5 purchases reported after at least 12 months of silence — most recent on 30 Nov 2020.